Global Calcium Folinate Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Calcium Folinate market size will reach US$ 192 million by 2031.
Calcium Folinate, also known as leucovorin calcium, is a drug similar to folic acid. Commonly used as an antidote to an overdose of antifolate metabolites, as well as Megaloblastic anemia and Leukopenia.
United States market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Calcium Folinate players cover Merck, Teva, Ingenus, Mylan, West-Ward Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Calcium Folinate Industry Forecast” looks at past sales and reviews total world Calcium Folinate sales in 2024, providing a comprehensive analysis by region and market sector of projected Calcium Folinate sales for 2025 through 2031. With Calcium Folinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calcium Folinate industry.
This Insight Report provides a comprehensive analysis of the global Calcium Folinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Calcium Folinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Calcium Folinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calcium Folinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calcium Folinate.
This report presents a comprehensive overview, market shares, and growth opportunities of Calcium Folinate market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tablet
Injection
Capsule
Segmentation by Application:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories
Please note: The report will take approximately 2 business days to prepare and deliver.
Calcium Folinate, also known as leucovorin calcium, is a drug similar to folic acid. Commonly used as an antidote to an overdose of antifolate metabolites, as well as Megaloblastic anemia and Leukopenia.
United States market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Calcium Folinate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Calcium Folinate players cover Merck, Teva, Ingenus, Mylan, West-Ward Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Calcium Folinate Industry Forecast” looks at past sales and reviews total world Calcium Folinate sales in 2024, providing a comprehensive analysis by region and market sector of projected Calcium Folinate sales for 2025 through 2031. With Calcium Folinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calcium Folinate industry.
This Insight Report provides a comprehensive analysis of the global Calcium Folinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Calcium Folinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Calcium Folinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calcium Folinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calcium Folinate.
This report presents a comprehensive overview, market shares, and growth opportunities of Calcium Folinate market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tablet
Injection
Capsule
Segmentation by Application:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Calcium Folinate Market Size by Player
- 4 Calcium Folinate by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Calcium Folinate Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
